BlossomHill Therapeutics to present at RAS summit and H.C. Wainwright conference
BlossomHill Therapeutics, Inc. said it will present at the 8th Annual RAS-Targeted Drug Development Summit and the H.C. Wainwright 28th Annual Global Investment Conference.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.